SCHEMBL7745330

SCHEMBL7745330

CSC(=S)NC1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.52
CYP3A4 P08684 2/20 0.52
ALDH1A1 P00352 1/20 0.52
TP53 P04637 1/20 0.52
IDO1 P14902 1/20 0.50
LMNA P02545 1/20 0.45
GAA P10253 1/20 0.45
NPC1 O15118 3/20 0.43
RAB9A P51151 2/20 0.43
MAPK1 P28482 1/20 0.43
DUSP3 P51452 1/20 0.43
PTPN5 P54829 1/20 0.43
PTPN11 Q06124 1/20 0.43
POLB P06746 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 2/20 0.42
SIGMAR1 Q99720 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19101077 0.90 IDO1 (0.53) SMN1; SMN2CYP3A4ALDH1A1TP53IDO1
SCHEMBL6950748 0.90
SCHEMBL3078929 0.78 ALDH1A1 (0.61) SMN1; SMN2CYP3A4ALDH1A1TP53LMNA
SCHEMBL3072017 0.78 ALDH1A1 (0.61) SMN1; SMN2CYP3A4ALDH1A1TP53LMNA
SCHEMBL7745327 0.76 SMN1; SMN2 (0.52) SMN1; SMN2CYP3A4ALDH1A1TP53LMNA
SCHEMBL14405489 0.74 ALDH1A1 (0.50) SMN1; SMN2CYP3A4ALDH1A1TP53LMNA
SCHEMBL27540143 0.73 ALDH1A1 (0.48) SMN1; SMN2CYP3A4ALDH1A1TP53LMNA
SCHEMBL6040382 0.72
SCHEMBL27759933 0.71 SMN1; SMN2 (0.46) SMN1; SMN2CYP3A4ALDH1A1TP53LMNA
SCHEMBL3062295 0.71 ALDH1A1 (0.52) SMN1; SMN2CYP3A4ALDH1A1TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001040244-A1 N6 HETEROCYCLIC 5' MODIFIED ADENOSINE DERIVATIVES CV THERAPEUTICS, INC. (US) 2001-06-07 WO claimed
WO-2001040244-A1 N6 HETEROCYCLIC 5' MODIFIED ADENOSINE DERIVATIVES CV THERAPEUTICS, INC. (US) 2001-06-07 WO disclosed